Dr Rieder reviews his presentation from the AIBD virtual regional meeting on August 27 on biosimilars for anti-tumor necrosis factor therapies, including ways to overcome the "nocebo effect" among patients.
Dr Rieder reviews his presentation from the AIBD virtual regional meeting on August 27 on biosimilars for anti-tumor necrosis factor therapies, including ways to overcome the "nocebo effect" among patients.
Dr Glassner discusses her presentation at the Advances in Inflammatory Bowel Diseases virtual regional meeting August 27 on the role of leukocyte trafficking in inflammatory bowel disease.
Dr Glassner discusses her presentation at the Advances in Inflammatory Bowel Diseases virtual regional meeting August 27 on the role of leukocyte trafficking in inflammatory bowel disease.
Dr Irani, from Houston Methodist Academic Institute-Weill Cornell, reviews his presentation at the virtual AIBD regional meeting August 27 on positioning various therapies for inflammatory bowel diseases.
Dr Irani, from Houston Methodist Academic Institute-Weill Cornell, reviews his presentation at the virtual AIBD regional meeting August 27 on positioning various therapies for inflammatory bowel diseases.
Dr Abraham, chair of the virtual Advances in Inflammatory Bowel Diseases regional meeting on August 27, reviews her presentation on setting treatment goals and appropriate strategies for meeting them when treating patients with IBD.
Dr Abraham, chair of the virtual Advances in Inflammatory Bowel Diseases regional meeting on August 27, reviews her presentation on setting treatment goals and appropriate strategies for meeting them when treating patients with IBD.
Dr Abraham, chair of the Advances in Inflammatory Bowel Diseases virtual regional meeting on August 27, reviews some of the topics and speakers to be featured at the meeting.
Dr Abraham, chair of the Advances in Inflammatory Bowel Diseases virtual regional meeting on August 27, reviews some of the topics and speakers to be featured at the meeting.
Dr Regueiro, chief of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation at the Advances in Inflammatory Bowel Diseases regional meeting on positioning and sequencing therapies for Crohn disease and...
Dr Regueiro, chief of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation at the Advances in Inflammatory Bowel Diseases regional meeting on positioning and sequencing therapies for Crohn disease and...
Dr Strong, from Northwestern Medicine in Chicago, reviews the key points of his lecture on the need for a team approach to perianal Crohn disease from the July 23 AIBD conference.
Dr Strong, from Northwestern Medicine in Chicago, reviews the key points of his lecture on the need for a team approach to perianal Crohn disease from the July 23 AIBD conference.
Dr Charabaty reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting in Chicago on helping patients plan for conception, choose the right medications, and ensure a healthy mom and baby.
Dr Charabaty reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting in Chicago on helping patients plan for conception, choose the right medications, and ensure a healthy mom and baby.
Dr Cohen discusses his talk on managing infections such as cytomegalovirus and histoplasmosis among patients with IBD, and testing for tuberculosis before starting immunosuppressive therapy.
Dr Cohen discusses his talk on managing infections such as cytomegalovirus and histoplasmosis among patients with IBD, and testing for tuberculosis before starting immunosuppressive therapy.
Dr Rubin, from the University of Chicago, discusses how using a treat to target approach can enhance patient quality of life, achieve tight control of inflammatory bowel disease, and ensure optimal outcomes.
Dr Rubin, from the University of Chicago, discusses how using a treat to target approach can enhance patient quality of life, achieve tight control of inflammatory bowel disease, and ensure optimal outcomes.